Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Mesothelioma, Malignant × Other solid neoplasm × Clear all

Phase

Phase 2 110 Phase 1 75 Phase 1/2 34 Phase NA 20 Phase 3 14 Phase EARLY_PHASE1 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma 4 Advanced Solid Tumor 2 Retinoblastoma 1 Resectable MMR-deficient Solid Tumors 1 Pediatric Patients With Solid Tumors 1 Pancreatic Ductal Adenocarcinoma 1 Mesothelioma, Malignant 1 All Solid Tumors 1 Advanced Intrahepatic Cholangiocarcinoma 1

Interventions

Pemetrexed 1 Cisplatin 1 Carboplatin 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02709512 2023-10-04

ATOMIC

Polaris Group

Phase 2/3 Completed

249 enrolled 17 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡